#1 Clinical Trials Search in Europe

Enfuvirtide

Enfuvirtide, also known by its brand name Fuzeon, is a drug used in the treatment of HIV infections. This article explores various clinical trials that have investigated the use of enfuvirtide in different scenarios, including its safety, efficacy, and administration methods. These trials provide valuable insights into how enfuvirtide can be used effectively in HIV treatment regimens, particularly for patients with advanced HIV infection or those who have developed resistance to other antiretroviral medications.

Table of Contents

What is Enfuvirtide?

Enfuvirtide, also known by its brand name Fuzeon, is a medication used in the treatment of Human Immunodeficiency Virus (HIV) infections. It belongs to a class of drugs called HIV fusion inhibitors, which work differently from other types of HIV medications[1]. Enfuvirtide is typically used in patients who have advanced HIV disease and have developed resistance to other antiretroviral drugs[2].

How Enfuvirtide Works

Enfuvirtide works by preventing HIV from entering and infecting healthy cells in your body. It does this by blocking the fusion of the virus with the cell membrane, which is a crucial step in the HIV infection process. By interfering with this step, enfuvirtide helps to reduce the amount of HIV in your body (known as viral load) and can potentially increase your CD4 cell count, which is an important measure of your immune system’s health[3].

Medical Conditions Treated

Enfuvirtide is specifically used to treat HIV-1 infections. It is not used as a first-line treatment but is typically prescribed for patients who have:

  • Advanced HIV disease
  • Developed resistance to other antiretroviral medications
  • Failed treatment with regimens containing drugs from each of the three main classes of anti-HIV drugs (nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, and protease inhibitors)[4]

How Enfuvirtide is Administered

Enfuvirtide is administered through subcutaneous injection, which means it is injected just under the skin. The typical dose is 90 milligrams (mg) twice daily. Here are some key points about its administration:

  • It is usually injected into the upper arm, upper thigh, or stomach area
  • Patients or their caregivers are typically trained to administer the injections at home
  • The medication is often used in combination with other antiretroviral drugs, known as an optimized background regimen[5]

In some cases, a needle-free injection device called Biojector 2000 has been studied for administering enfuvirtide. This device uses high pressure to push the medication through the skin without a needle[6].

Effectiveness of Enfuvirtide

Clinical trials have shown that adding enfuvirtide to an optimized background regimen can lead to a greater reduction in viral load compared to the optimized background regimen alone. This is particularly important for patients who have limited treatment options due to drug resistance[4].

In some studies, enfuvirtide has also been investigated for its potential to further suppress HIV in patients who already have undetectable viral loads on their current treatment. This could potentially lead to a reduction in the size of the viral reservoir, which is a group of cells where HIV can hide and persist despite treatment[3].

Side Effects and Safety

Like all medications, enfuvirtide can cause side effects. The most common side effects include:

  • Injection site reactions: These can include pain, redness, itching, hardened skin, or bumps at the injection site
  • Increased risk of certain infections: Particularly bacterial pneumonia
  • Allergic reactions: In rare cases, patients may experience severe allergic reactions

It’s important to discuss any side effects with your healthcare provider. They can help manage these effects or adjust your treatment if necessary[1][2].

Special Considerations

There are a few special considerations to keep in mind with enfuvirtide:

  • Use in children and adolescents: Enfuvirtide has been studied in HIV-infected children and adolescents aged 3 to 16 years. The dosing and safety profile may be different for these age groups[7].
  • Use during stem cell transplantation: Enfuvirtide has been studied as a way to maintain HIV treatment in patients undergoing stem cell transplantation when they are unable to take oral medications[8].
  • Metabolic effects: Some studies have investigated the potential effects of enfuvirtide on lipid and glucose metabolism, which are important considerations for long-term HIV treatment[9].

Remember, enfuvirtide is a specialized medication typically used in advanced HIV cases. It should only be used under the close supervision of an HIV specialist. Always follow your healthcare provider’s instructions and report any concerns or side effects promptly.

Aspect Details
Drug Name Enfuvirtide (Fuzeon)
Drug Class HIV fusion inhibitor
Administration Subcutaneous injection, typically 90 mg twice daily
Target Population Patients with advanced HIV infection or resistance to other antiretrovirals
Key Findings – Effective in reducing viral load when combined with other antiretrovirals
– Useful for patients with limited treatment options
– Alternative administration methods (e.g., needle-free devices) explored
– Potential metabolic effects investigated
Common Side Effects Injection site reactions (pain, redness, itching, lumps)
Special Considerations – Used in combination with optimized background regimen
– Pharmacokinetic studies conducted in different age groups
– Potential use during stem cell transplantation in HIV patients

FAQ

  • What is enfuvirtide (Fuzeon)? Enfuvirtide, also known as Fuzeon, is an antiretroviral medication used to treat HIV infections. It belongs to a class of drugs called HIV fusion inhibitors, which work by preventing the virus from entering and infecting healthy cells in the body.
  • How is enfuvirtide administered? Enfuvirtide is typically administered as a subcutaneous injection, meaning it is injected under the skin. The usual dose is 90 mg twice daily. Some trials have explored alternative administration methods, such as using needle-free injection devices.
  • Who might benefit from enfuvirtide treatment? Enfuvirtide is often used in patients with advanced HIV infection or those who have developed resistance to other antiretroviral medications. It is typically used in combination with other HIV drugs as part of a comprehensive treatment plan.
  • What are some common side effects of enfuvirtide? Common side effects of enfuvirtide include injection site reactions such as pain, redness, itching, or lumps at the injection site. Other potential side effects may include fatigue, nausea, and increased risk of certain infections.
  • How effective is enfuvirtide in treating HIV? Clinical trials have shown that enfuvirtide, when used in combination with other antiretroviral drugs, can help reduce viral load and improve immune function in HIV patients, particularly those with limited treatment options due to drug resistance.

Ongoing Clinical Trials on Enfuvirtide

  • Study on the Effects of Abacavir Sulfate and Etravirine in Pregnant Women with HIV

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Germany Ireland The Netherlands Spain

Glossary

  • Antiretroviral therapy (ART): A combination of medications used to treat HIV infection by suppressing the virus and slowing the progression of the disease.
  • CD4+ T cells: A type of white blood cell that plays a crucial role in the immune system and is targeted by HIV.
  • Fusion inhibitor: A class of antiretroviral drugs that prevent HIV from entering and infecting healthy cells by blocking the fusion of the virus with the cell membrane.
  • HIV-1: The most common type of Human Immunodeficiency Virus, which causes AIDS.
  • Viral load: The amount of HIV in a person's blood, typically measured as the number of copies of the virus per milliliter of blood.
  • Subcutaneous injection: An injection that delivers medication into the layer of tissue between the skin and muscle.
  • Optimized background regimen (OB): A customized combination of antiretroviral drugs selected based on a patient's treatment history and resistance profile.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Genotypic resistance testing: A test that analyzes the genetic structure of HIV to identify mutations associated with drug resistance.
  • Phenotypic resistance testing: A laboratory test that measures the ability of HIV to grow in the presence of antiretroviral drugs to determine resistance.

References

  1. https://clinicaltrials.gov/study/NCT02582983
  2. https://clinicaltrials.gov/study/NCT02569502
  3. https://clinicaltrials.gov/study/NCT00334022
  4. https://clinicaltrials.gov/study/NCT00021554
  5. https://clinicaltrials.gov/study/NCT00008528
  6. https://clinicaltrials.gov/study/NCT00337701
  7. https://clinicaltrials.gov/study/NCT00022763
  8. https://clinicaltrials.gov/study/NCT01836068
  9. https://clinicaltrials.gov/study/NCT00657761